These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30304334)

  • 21. What Will It Take to Achieve Equity in Policies Restricting Menthol and Other Flavored Nicotine and Commercial Tobacco Products?
    Smiley SL; Rose SW
    Nicotine Tob Res; 2024 May; 26(Supplement_2):S61-S64. PubMed ID: 38817029
    [No Abstract]   [Full Text] [Related]  

  • 22. The Tobacco 21 Movement and Electronic Nicotine Delivery System Use Among Youth.
    Meernik C; Baker HM; Lee JG; Goldstein AO
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 27940513
    [No Abstract]   [Full Text] [Related]  

  • 23. Facilitators and Barriers to Passing Local Policies That Prohibit the Sale of Flavored Tobacco Products: Qualitative Analysis of Strategies Implemented by 36 Communities in California, 2017-2021.
    Hellesen S; Haun S; Dove MS
    Prev Chronic Dis; 2024 May; 21():E36. PubMed ID: 38815050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["Nicotine industry: risk reduction,an exclusively financial objective"].
    Martinet Y; Béguinot E; Diethelm P; Wirth N
    Rev Prat; 2021 Jan; 71(1):27-32. PubMed ID: 34160934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should e-cigarette use be permitted in smoke-free public places? No.
    Chapman S; Daube M; Maziak W
    Tob Control; 2017 Mar; 26(e1):e3-e4. PubMed ID: 27821791
    [No Abstract]   [Full Text] [Related]  

  • 26. Tobacco point-of-sale advertising in downtown Buenos Aires, Argentina and compliance with the new tobacco advertising restrictions.
    Minter DJ; Mejia R; Salas I; Thrasher J; Pérez-Stable EJ
    Tob Control; 2017 Mar; 26(2):239-240. PubMed ID: 27030591
    [No Abstract]   [Full Text] [Related]  

  • 27. Advancing Tobacco Control Through Point of Sale Policies, Providence, Rhode Island.
    Pearlman DN; Arnold JA; Guardino GA; Welsh EB
    Prev Chronic Dis; 2019 Sep; 16():E129. PubMed ID: 31538567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conflicts and controversies in contemporary tobacco control.
    Malone RE
    Tob Control; 2017 Mar; 26(e1):e1-e2. PubMed ID: 28325775
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of the Flavored Cigarette Ban on Adolescent Tobacco Use.
    Courtemanche CJ; Palmer MK; Pesko MF
    Am J Prev Med; 2017 May; 52(5):e139-e146. PubMed ID: 28081999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavored tobacco product use among U.S. young adults.
    Villanti AC; Richardson A; Vallone DM; Rath JM
    Am J Prev Med; 2013 Apr; 44(4):388-391. PubMed ID: 23498105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Term Impact of a Flavored Tobacco Restriction: Changes in Youth Tobacco Use in a Massachusetts Community.
    Kingsley M; Setodji CM; Pane JD; Shadel WG; Song G; Robertson J; Kephart L; Henley P; Ursprung WWS
    Am J Prev Med; 2019 Dec; 57(6):741-748. PubMed ID: 31668668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?
    Bialous SA; van der Eijk Y
    AMA J Ethics; 2020 Feb; 22(2):E135-146. PubMed ID: 32048584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electronic cigarette: a wolf in sheep's clothing.
    Neuberger M
    Wien Klin Wochenschr; 2015 May; 127(9-10):385-7. PubMed ID: 26230008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing use of flavoured tobacco products amongst youth.
    Gupta AK; Mehrotra R
    Indian J Tuberc; 2021; 68S():S105-S107. PubMed ID: 34538383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Two-Wave Observational Study of Compliance With Youth Access and Tobacco Advertising Provisions of the Cigarettes and Other Tobacco Products Act in India.
    Mead EL; Rimal RN; Cohen JE; Turner MM; Lumby EC; Feighery EC; Shah V
    Nicotine Tob Res; 2016 May; 18(5):1363-70. PubMed ID: 26610937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronic cigarette advertising at the point-of-sale: a gap in tobacco control research.
    Ganz O; Cantrell J; Moon-Howard J; Aidala A; Kirchner TR; Vallone D
    Tob Control; 2015 Mar; 24(e1):e110-2. PubMed ID: 24619455
    [No Abstract]   [Full Text] [Related]  

  • 37. Philip Morris research on precursors to the modern e-cigarette since 1990.
    Dutra LM; Grana R; Glantz SA
    Tob Control; 2017 Dec; 26(e2):e97-e105. PubMed ID: 27852893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA's regulatory shift on tobacco control.
    Yang YT
    Prev Med; 2018 Aug; 113():153-155. PubMed ID: 29866276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prohibition of tobacco sales to minors in France and Quebec. Comparison of legislative frameworks, their enforcement, and underage smoking].
    Elharrar X; Fortin M; Beguinot E; Dols AM; Greillier L; Martinet Y
    Rev Epidemiol Sante Publique; 2019 May; 67(3):181-187. PubMed ID: 30954324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Industry tactics in anticipation of strengthened regulation: BIDI Vapor unveils non-characterising BIDI Stick flavours on digital media platforms.
    Kostygina G; Kreslake JM; Borowiecki M; Kierstead EC; Diaz MC; Emery SL; Schillo B
    Tob Control; 2023 Jan; 32(1):121-123. PubMed ID: 34078653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.